NUVB Nuvation Bio Inc.
Health Care, filed as NUVATION BIO INC (COM CL A), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab
Bought by 1 manager in 2026 Q3, sold by 1
In 2026 Q3 Torray Investment Partners opened a position in Nuvation Bio, while Stanley Druckenmiller trimmed.
Who owns this now
Largest portfolio weights among holders, up to 0.3% (Stanley Druckenmiller, Duquesne Family Office). Not free-float ownership.
Who owns NUVB
Sorted by value, long equity only, as of 2026 Q3.
| History | |||||
|---|---|---|---|---|---|
| Stanley Druckenmiller, Duquesne Family Office | Reduce −50.0% | 2,269,900 | $13M | History | |
| David Abrams, Abrams Capital Management | Hold | 1,270,504 | $7.1M | History | |
| Palo Alto Investors | Hold | 326,609 | $1.8M | History | |
| Torray Investment Partners | New 0.20% | 274,814 | $1.5M | History | |
| David Einhorn, DME Capital Management | Hold | 34,995 | $196K | History |
Insider trades
Open-market buys and sales by NUVB's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $118K bought by 1 insider
- $1.3M sold by 1 insider outside a trading plan
- $3.5M sold by 5 insiders under 10b5-1 plans
-
Gary Hattersley Chief Scientific OfficerPlanned sale$709K 100,000 shares at $7.09 100% of stakeTraded Aug 19 Filed Aug 21
-
Philippe Sauvage CFOPlanned sale$286K 47,668 shares at $6.01 79% of stakeTraded Jun 23 Filed Jun 24
-
Stacy Markel Chief People OfficerPlanned sale$753K 125,000 shares at $6.03 79% of stakeTraded Jun 23 Filed Jun 24
-
Kerry Wentworth Chief Regulatory OfficerPlanned sale$379K 63,000 shares at $6.02 54% of stakeTraded Jun 23 Filed Jun 24
-
Robert Mashal DirectorBuy$118K 25,000 shares at $4.73 +13% to stakeTraded Jun 9 Filed Jun 11
-
Dongfang Liu Chief Medical OfficerPlanned sale$251K 50,000 shares at $5.02 74% of stakeTraded Apr 17 Filed Apr 21
-
Kerry Wentworth Chief Regulatory OfficerPlanned sale$184K 36,750 shares at $5.01 41% of stakeTraded Apr 17 Filed Apr 21
-
Kerry Wentworth Chief Regulatory OfficerPlanned sale$904K 200,000 shares at $4.52 79% of stakeTraded Apr 6 Filed Apr 8
-
Dongfang Liu Chief Medical OfficerSale$1.2M 150,000 shares at $7.82 89% of stakeTraded Dec 1, 2025 Filed Dec 3, 2025
-
Dongfang Liu Chief Medical OfficerSale$155K 20,000 shares at $7.75 53% of stakeTraded Nov 25–26 Filed Nov 26, 2025
-
Dongfang Liu Chief Medical OfficerSale$140K 20,000 shares at $7.00 53% of stakeTraded Nov 20, 2025 Filed Nov 24, 2025
-
Gary Hattersley Chief Scientific OfficerSale$2.7M 369,051 shares at $7.23 100% of stakeTraded Nov 20, 2025 Filed Nov 24, 2025
-
David C. Hanley Chief Technical OperationsSale$1.4M 200,000 shares at $7.14 89% of stakeTraded Nov 19, 2025 Filed Nov 21, 2025
-
Dongfang Liu Chief Medical OfficerSale$148K 30,000 shares at $4.93 63% of stakeTraded Nov 17–19 Filed Nov 19, 2025
-
Gary Hattersley Chief Scientific OfficerPlanned sale$502K 100,000 shares at $5.02 100% of stakeTraded Oct 27, 2025 Filed Oct 29, 2025
Also filed in the last 12 months, not counted as buying or selling: 14 option exercises and 1 stock grant.
SEC filings
Recent issuer filings from EDGAR, 14 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 2.03,8.01,9.01 | Filing Doc | |
| 8-K | 1.01,1.02,2.03,8.01,9.01 | Filing Doc | |
| 424B5 | Filing Doc | ||
| 424B5 | Filing Doc | ||
| 8-K | 5.07 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| 10-K | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $616.43M | $526.26M | $571.52M |
| Total non-current assets * | $5.05M | $14.37M | $23.3M |
| Total assets | $621.48M | $540.63M | $594.82M |
| Total current liabilities | $13.97M | $58.24M | $82.23M |
| Total non-current liabilities * | $2.39M | $18.59M | $206.88M |
| Total equity | $605.12M | $463.79M | $305.72M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon